Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person
South San Francisco, CA — November 23, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
Read more
Bristol Myers Squibb Announces Deucravacitinib (BMS-986165) Demonstrated Superiority to Placebo and Otezla® (apremilast) in Pivotal Phase 3 Psoriasis Study
PRINCETON, N.J.–(BUSINESS WIRE) November 3, 2020 — Bristol Myers Squibb (NYSE:BMY) today announced positive results from POETYK PSO-1, the first
Read more
RedHill Biopharma Announces FDA Orphan Drug Designation for RHB-204 for the Treatment of NTM Infections
TEL AVIV, Israel and RALEIGH, NC, October 14, 2020, RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today
Read more
US firm announces ‘positive interim’ phase 1 results for virus vaccine
US biotech firm Moderna reported “positive interim” results on Monday in the first clinical tests of its vaccine against the
Read more
Singapore announces first local coronavirus transmissions
Singapore on Tuesday announced the first local transmissions of the deadly coronavirus from China as a major aviation conference was
Read more